| Cheryl A Rodriguez, LPN | |
|
720 Chicago St, Racine, WI 53405-2648 | |
| (262) 634-3558 | |
| Not Available |
| Full Name | Cheryl A Rodriguez |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 720 Chicago St, Racine, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669528873 | NPI | - | NPPES |
| 3927648400 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 11232-031 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Cheryl A Rodriguez, LPN 9312 S 33rd St, Franklin, WI 53132-9153 Ph: (414) 761-9518 | Cheryl A Rodriguez, LPN 720 Chicago St, Racine, WI 53405-2648 Ph: (262) 634-3558 |
News Archive
BG Medicine, a life sciences company focused on the discovery, development, and commercialization of novel diagnostics, today announced the publication of a study exploring the predictive value of plasma galectin-3 levels in heart failure (HF) patients with reduced and preserved ejection fraction.
In operation since recently at the Centre hospitalier de l'Université de Montréal (CHUM), the CyberKnife(R) Robotic Radiosurgery System, is revolutionizing the treatment of both cancerous and non-cancerous tumors anywhere in the body. Used in radiation oncology, the CyberKnife System is the latest word in radiosurgery technology. Designed to destroy tumours using radiation beams, it is the first system of its kind to treat tumors non-invasively to be installed in Canada.
AVANIR Pharmaceuticals, Inc. today announced that the United States Patent and Trademark Office (USPTO) has issued the Company a new patent for its lead drug candidate Zenvia™ (dextromethorphan/quinidine), extending the period of patent protection in the United States into late 2025. U.S. patent number 7,659,282 titled "Pharmaceutical Compositions Comprising Dextromethorphan and Quinidine for the Treatment of Neurological Disorders" was issued on February 9, 2010. The new patent will provide AVANIR with patent protection for low-dose quinidine formulations of Zenvia used to treat pseudobulbar affect (PBA).
Currently, the only therapy for metabolic liver disease is an organ transplant. Tracy Grikscheit, MD, an attending physician and regenerative medicine scientist at Children's Hospital Los Angeles, hopes to change that reality.
› Verified 6 days ago
Falon Wilson, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1112 Grove Ave, Racine, WI 53405 Phone: 262-902-4429 | |
Aleeshia Williams, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1700 Franklin St, Racine, WI 53403 Phone: 262-497-1643 | |
Mrs. Donna Rae Lester, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 5927 Spring St, Racine, WI 53406 Phone: 262-886-4801 | |
Kala C Barker, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 6233 Bankers Rd, Suite 10, Racine, WI 53403 Phone: 262-549-6600 Fax: 262-549-6698 | |
Corine Baumstark, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1903 English St, Racine, WI 53404 Phone: 262-995-5629 | |
Stephanie Angel Compton, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 815 8th St Apt 214, Racine, WI 53403 Phone: 262-994-5049 | |
Monique Price, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1517 Augusta St, Racine, WI 53402 Phone: 262-995-7071 |